Imatge de la portada

Influence of 4‐week or 12‐week glucocorticoid treatment on metabolic changes in patients with active moderate‐to‐severe thyroid‐associated ophthalmopathy

Abstract Thyroid‐associated ophthalmopathy (TAO) is a serious, progressive, vision‐threatening and difficult‐to‐treat organ‐specific autoimmune disease. The course, therapeutic effects and prognosis of moderate to severe TAO vary greatly. High‐dose intravenous glucocorticoid (IVGC) therapy is consid...

Descripció completa

Guardat en:

Dades bibliogràfiques
Autors principals:	Xiaoman Chen (Autor), Buatikamu Abudukerimu (Autor), Qin Li (Autor), Qing Li (Autor), Jie Qiao (Autor), Dongping Lin (Autor), Chunhua Sui (Autor), Lin Ye (Autor), Hualing Zhai (Autor), Boren Jiang (Autor), Ningjian Wang (Autor), Mengda Jiang (Autor), Xiaofeng Tao (Autor), Ziyang Shao (Autor), Chenfang Zhu (Autor), Yubo Ma (Autor), Ping Xiong (Autor), Jing Sun (Autor), Huifang Zhou (Autor), Bing Han (Autor), Yingli Lu (Autor)
Format:	Llibre
Publicat:	Wiley, 2021-09-01T00:00:00Z.
Matèries:	article
Accés en línia:	Connect to this object online.
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Graves' ophthalmopathy - thyroid eye disease
per: Dagna Siedlecka, et al.
Publicat: (2019)

Treatment of ophthalmopathy in the course of Graves' disease
per: Magdalena Woźniak, et al.
Publicat: (2019)

Treatment of ophthalmopathy in the course of Graves' disease
per: Magdalena Woźniak, et al.
Publicat: (2019)

Graves' ophthalmopathy - thyroid eye disease
per: Dagna Siedlecka, et al.
Publicat: (2019)

Precision Medicine in Graves' Disease and Ophthalmopathy
per: Giusy Elia, et al.
Publicat: (2021)

Practical Guidelines Management of Graves Ophthalmopathy
per: Imam Subekti, et al.
Publicat: (2019)

Current and promising therapies based on the pathogenesis of Graves' ophthalmopathy
per: Xin Zhang, et al.
Publicat: (2023)

Mechanisms of Spica Prunellae against thyroid-associated Ophthalmopathy based on network pharmacology and molecular docking
per: Yuhan Zhang, et al.
Publicat: (2020)

Massive blood transfusion for a pregnant woman with placenta increta at 26 weeks of gestation
per: LinLin Wang, et al.
Publicat: (2024)

COVID-associated neuro-ophthalmopathy. Issues of diagnosis and treatment
per: Igor N. Stepanov, et al.
Publicat: (2022)

Asssociation of vitamin D with autoimmune ophthalmopathy in Graves' disease
per: Yu.V. Buldygina, et al.
Publicat: (2020)

On selenium deficiency in Graves' disease patients with autoimmune ophthalmopathy
per: Yu.V. Buldygina, et al.
Publicat: (2019)

Thymic stromal lymphopoietin gene promoter polymorphisms and expression levels in Graves' disease and Graves' ophthalmopathy
per: Tsai Kun-Hsi, et al.
Publicat: (2012)

The association of non-alcoholic fatty liver disease with thyroid peroxidase and thyroglobulin antibody: A new insight from SPECT-China study
per: Yi Chen, et al.
Publicat: (2018)

Case Report of Congenital Hepatoblastoma With the Onset at 30-Weeks' Gestation
per: Zheng Yan, et al.
Publicat: (2022)

Toll-like receptor gene polymorphisms are associated with susceptibility to graves' ophthalmopathy in Taiwan males
per: Liu Yu-Huei, et al.
Publicat: (2010)

Three Weeks
per: Glyn, Elinor, 1864-1943

Texas Week
per: Hernhuter, Albert, 1934-

Rainy Week
per: Abbott, Eleanor Hallowell, 1872-1958

Fortieth week
per: Sérgio Cavalheiro
Publicat: (2020)

Weekly docetaxel in an elderly patient with refractory classic Kaposi sarcoma
per: Rongbo Lin
Publicat: (2016)

Blood lead level is associated with non-alcoholic fatty liver disease in the Yangtze River Delta region of China in the context of rapid urbanization
per: Hualing Zhai, et al.
Publicat: (2017)

Orbital US-based characteristics in Graves' disease-associated autoimmune ophthalmopathy
per: Yu.V. Buldygina, et al.
Publicat: (2020)

RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves' Ophthalmopathy
per: Dominika Łacheta, et al.
Publicat: (2021)

Risk prediction models of gestational diabetes mellitus before 16 gestational weeks
per: Yiling Wei, et al.
Publicat: (2022)

Lessons of the War: Being Comments from Week to Week to the Relief of Ladysmith
per: Wilkinson, Spenser, 1853-1937

MiR-143 Targets IGF-1R to Suppress Autoimmunity in Thyroid-Associated Ophthalmopathy
per: Tang W, et al.
Publicat: (2022)

Analysis of research hotspots and trends in pediatric ophthalmopathy based on 10 years of WoSCC literature
per: Qianfang Jia, et al.
Publicat: (2024)

Optimal LDR to Protect the Kidney From Diabetes: Whole-Body Exposure to 25 mGy X-rays Weekly for 8 Weeks Efficiently Attenuates Renal Damage in Diabetic Mice
per: Jie Cheng, et al.
Publicat: (2018)

The Association of Weekly pre-Hemodialysis Systolic Blood Pressure and Following Week Mortality
per: Dugan Maddux, et al.
Publicat: (2018)

Once a week
per: Milne, A. A. (Alan Alexander), 1882-1956

Two Weeks in August
per: Robinson, Frank M., 1926-2014; MacIntyre, Elizabeth [Illustrator]

Cleft awareness week
per: Karoon Agrawal
Publicat: (2016)

The mothers' breastfeeding behaviour within six weeks postpartum: new scale development and psychometric validation study
per: Jing-Ling Wu, et al.
Publicat: (2023)

Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways
per: Yamei Liu, et al.
Publicat: (2022)

Dose-dense chemotherapy with weekly paclitaxel and 3-weekly carboplatin for recurrent ovarian cancer
per: Wei-Chun Chen, et al.
Publicat: (2020)

Corrigendum: Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways
per: Yamei Liu, et al.
Publicat: (2023)

Incremental Cost of Prematurity by Week of Gestational Age
per: Eileen M. Walsh, et al.
Publicat: (2019)

Are Thyroid Autoimmune Diseases Associated with Cardiometabolic Risks in a Population with Normal Thyroid-Stimulating Hormone?
per: Yi Chen, et al.
Publicat: (2018)

Development and psychometric properties of the Thai Graves' ophthalmopathy quality of life (GO-QOL) questionnaire
per: Mingkwan Lumyongsatien, et al.
Publicat: (2019)